BIMI International Medical Inc. Announces Appointment of New Chief Financial Officer
19 Julho 2021 - 9:05AM
BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the
“Company”), a leading healthcare products and services provider in
China, today announced the appointment of Amy Xue as the Company’s
new Chief Financial Officer, effective July 15, 2021.
Xue is a CPA and ACCA certified accountant and experienced
senior finance executive. Prior to her appointment as BIMI’s Chief
Financial Officer, she served as CFO at iFresh, Inc. (NASDAQ:IFMK)
between March 2020 and June 2021. She has also served as the CFO of
Goldenbridge Acquisition Ltd. since March 2020 and is also the
Audit Committee Chairwoman at MingZhu Logistics Holdings Limited
(Nasdaq:YGMZ) since September 2020. From July 2018 to March 2020,
Xue served as CFO at XT Energy Group, Inc, in charge of
XTEG’s communication with SEC, investors and overseeing periodical
financial reports. She has also been a partner of Capital Market
Accounting Services at Wall Street CPA Services, LLC since November
2010, providing accounting consulting services to public companies
listed in US.
Mr Tiewei Song, Chief Executive Officer and President of the
Company, commented: “Ms Xue has a breadth of experience and
extensive expertise in capital market transactions and driving
efficiencies that will be key for the future of BIMI. Her
appointment positions the company strategically for the future as
we prepare to take the next steps to drive BIMI’s financial growth,
which will see the Company solidify its position as a leading
provider of healthcare products and services in China.”
About BIMI International Medical Inc.
BIMI International Medical Inc. was founded in 2006. The Company
is now exclusively a healthcare products and provider, offering a
broad range of healthcare products and related services and
operates two private hospitals in China. For more information,
please visit www.usbimi.com.
Safe Harbor Statement
Certain matters discussed in this news release are
forward-looking statements that involve a number of risks and
uncertainties including, but not limited to, the Company’s ability
to achieve profitable operations, its ability to continue to
operate as a going concern, its ability to continue to meet NASDAQ
continued listing requirements, the effects of the spread of
COVID-19, the demand for the Company’s products and services in the
People’s Republic of China, general economic conditions and other
risk factors detailed in the Company’s annual report and other
filings with the United States Securities and Exchange
Commission.
Investor Relations Contact:
Janice WangEverGreen Consulting Inc.Email:
IR@changqingconsulting.comPhone: +1 571-464-9470 (from U.S.)
+86
13811768559 (from China)
iFresh (NASDAQ:IFMK)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
iFresh (NASDAQ:IFMK)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024